GB0716591D0 - Composition - Google Patents

Composition

Info

Publication number: GB0716591D0
Authority: GB; United Kingdom
Prior art keywords: composition
Prior art date: 2007-08-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0716591A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

VERENIGING HET NEDERLANDS KANKER INSTITUUT

SLOTERVAART PARTICIPATIES BV

Original Assignee

VERENIGING HET NEDERLANDS KANKER INSTITUUT

SLOTERVAART PARTICIPATIES BV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-24

Filing date

2007-08-24

Publication date

2007-10-03

2007-08-24 Application filed by VERENIGING HET NEDERLANDS KANKER INSTITUUT, SLOTERVAART PARTICIPATIES BV filed Critical VERENIGING HET NEDERLANDS KANKER INSTITUUT

2007-08-24 Priority to GB0716591A priority Critical patent/GB0716591D0/en

2007-10-03 Publication of GB0716591D0 publication Critical patent/GB0716591D0/en

2008-08-22 Priority to EP08788414.4A priority patent/EP2190413B1/en

2008-08-22 Priority to MX2010002179A priority patent/MX2010002179A/en

2008-08-22 Priority to ES08788414.4T priority patent/ES2535401T3/en

2008-08-22 Priority to BRPI0816144-5A2A priority patent/BRPI0816144A2/en

2008-08-22 Priority to PCT/GB2008/002854 priority patent/WO2009027644A2/en

2008-08-22 Priority to AU2008291930A priority patent/AU2008291930B2/en

2008-08-22 Priority to CA2696622A priority patent/CA2696622C/en

2008-08-22 Priority to RU2010110658/15A priority patent/RU2488384C2/en

2008-08-22 Priority to JP2010521478A priority patent/JP5404625B2/en

2008-08-22 Priority to CN2008801042752A priority patent/CN101854919B/en

2008-08-22 Priority to KR1020107004111A priority patent/KR101544498B1/en

2009-08-24 Priority to ARP090103252A priority patent/AR073123A1/en

2009-08-24 Priority to CL2009001766A priority patent/CL2009001766A1/en

2009-08-24 Priority to US13/060,037 priority patent/US20110207804A1/en

2010-02-23 Priority to ZA2010/01304A priority patent/ZA201001304B/en

2010-02-23 Priority to IL204115A priority patent/IL204115B/en

2010-11-25 Priority to HK10110968.5A priority patent/HK1144390A1/en

Status Ceased legal-status Critical Current

Links

GB0716591A 2007-08-24 2007-08-24 Composition Ceased GB0716591D0 (en)

Priority Applications (18)

Application Number	Priority Date	Filing Date	Title
GB0716591A GB0716591D0 (en)	2007-08-24	2007-08-24	Composition
KR1020107004111A KR101544498B1 (en)	2007-08-24	2008-08-22	Compositions for the treatment of neoplastic diseases
RU2010110658/15A RU2488384C2 (en)	2007-08-24	2008-08-22	Compositions for treating neoplastic diseases
CN2008801042752A CN101854919B (en)	2007-08-24	2008-08-22	Compositions for the treatment of neoplastic diseases
ES08788414.4T ES2535401T3 (en)	2007-08-24	2008-08-22	Compositions for the treatment of neoplastic diseases
BRPI0816144-5A2A BRPI0816144A2 (en)	2007-08-24	2008-08-22	COMPOSITION
PCT/GB2008/002854 WO2009027644A2 (en)	2007-08-24	2008-08-22	Composition
AU2008291930A AU2008291930B2 (en)	2007-08-24	2008-08-22	Compositions for the treatment of neoplastic diseases
CA2696622A CA2696622C (en)	2007-08-24	2008-08-22	Compositions for the treatment of neoplastic diseases
EP08788414.4A EP2190413B1 (en)	2007-08-24	2008-08-22	Compositions for the treatment of neoplastic diseases
JP2010521478A JP5404625B2 (en)	2007-08-24	2008-08-22	Composition
MX2010002179A MX2010002179A (en)	2007-08-24	2008-08-22	Composition.
US13/060,037 US20110207804A1 (en)	2007-08-24	2009-08-24	Compositions for the treatment of neoplastic diseases
ARP090103252A AR073123A1 (en)	2007-08-24	2009-08-24	PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTANTIALLY AMORFO TAXANE TO BE USED IN THE TREATMENT OF NEOPLASIC DISEASE
CL2009001766A CL2009001766A1 (en)	2007-08-24	2009-08-24	Solid pharmaceutical composition for oral administration comprising: a defined substantially amorphous taxane, a defined hydrophilic carrier and a defined surfactant; method of preparing the composition; and its use to treat neoplastic disease.
ZA2010/01304A ZA201001304B (en)	2007-08-24	2010-02-23	Compositions for the treatment of neoplastic diseases
IL204115A IL204115B (en)	2007-08-24	2010-02-23	Compositions comprising a taxane and a surfactant and uses thereof in the treatment of neoplastic disease
HK10110968.5A HK1144390A1 (en)	2007-08-24	2010-11-25	Compositions for the treatment of neoplastic diseases

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0716591A GB0716591D0 (en)	2007-08-24	2007-08-24	Composition

Publications (1)

Publication Number	Publication Date
GB0716591D0 true GB0716591D0 (en)	2007-10-03

Family

ID=38599259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0716591A Ceased GB0716591D0 (en)	2007-08-24	2007-08-24	Composition

Country Status (6)

Country	Link
JP (1)	JP5404625B2 (en)
CN (1)	CN101854919B (en)
BR (1)	BRPI0816144A2 (en)
ES (1)	ES2535401T3 (en)
GB (1)	GB0716591D0 (en)
RU (1)	RU2488384C2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR086913A1 (en) *	2011-06-14	2014-01-29	Novartis Ag	4-METIL-3 - [[4- (3-PIRIDINIL) -2-PIRIMIDINIL] -AMINO] -N- [5- (4-METHYL-1H-IMIDAZOL-1-IL) -3- (TRIFLUORO-METIL) -FENIL] -BENZAMIDA AMORFA, FORM OF DOSAGE THAT CONTAINS AND METHOD TO PREPARE
WO2015152433A1 (en) *	2014-03-31	2015-10-08	Hanmi Pharm. Co., Ltd.	Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
CN105106420A (en) *	2015-07-30	2015-12-02	马衍福	Antineoplastic traditional Chinese medicine preparation
CN118948828A (en) *	2017-03-15	2024-11-15	Dfb索里亚有限责任公司	Topical therapy using taxane nanoparticles for the treatment of skin malignancies
US11957758B2 (en)	2017-09-07	2024-04-16	Shenzhen Salubris Pharmaceuticals Co. Ltd.	Pharmaceutical composition of docetaxel conjugate and preparation method
BR112021012255A2 (en)	2018-12-21	2021-09-28	Modra Pharmaceuticals B.V.	METHOD FOR TREATMENT OF CANCER IN A PATIENT, METHOD FOR REDUCING SIDE EFFECTS OF TREATMENT OF CANCER IN A PATIENT, COMBINATION OF A CYP3A INHIBITOR AND DOCETAXEL FOR USE IN A MEDICAL TREATMENT OF A CANCER, DOCETAXEL FOR USE IN A THERAPY OF COMBINATION IN THE TREATMENT OF CANCER, CYP3A INHIBITOR FOR USE IN A COMBINATION THERAPY IN THE TREATMENT OF CANCER, USE AND KIT COMPRISING A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING DOCETAXEL AND A PHARMACEUTICAL COMPOSITION COMPRISING A CYP3A INHIBITOR
BR112021012266A2 (en) *	2018-12-21	2021-08-31	Modra Pharmaceuticals B.V.	DOCETAXEL FOR USE IN A COMBINATION THERAPY IN THE TREATMENT OF CANCER, CY3A INHIBITOR FOR USE IN A COMBINATION THERAPY IN THE TREATMENT OF CANCER, DOCETAXEL OR A CY3A INHIBITOR FOR USE IN A COMBINATION THERAPY, METHOD FOR THE TREATMENT OF A CANCER METASTATIC CASTRATION RESISTANT PROSTATE AND KIT

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1180020B2 (en) *	1999-05-27	2009-06-24	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
EP1539111A1 (en) *	2002-08-05	2005-06-15	DSM IP Assets B.V.	Oral dosage forms of water insoluble drugs and methods of making the same
KR100508518B1 (en) *	2002-11-13	2005-08-17	한미약품 주식회사	Method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby
AU2002350719A1 (en) *	2002-11-29	2004-06-23	Janssen Pharmaceutica N.V.	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2006026592A2 (en) *	2004-08-27	2006-03-09	Spherics, Inc.	Oral administration of poorly absorbed drugs, methods and compositions related thereto

2007
- 2007-08-24 GB GB0716591A patent/GB0716591D0/en not_active Ceased
2008
- 2008-08-22 CN CN2008801042752A patent/CN101854919B/en active Active
- 2008-08-22 BR BRPI0816144-5A2A patent/BRPI0816144A2/en not_active Application Discontinuation
- 2008-08-22 RU RU2010110658/15A patent/RU2488384C2/en active
- 2008-08-22 ES ES08788414.4T patent/ES2535401T3/en active Active
- 2008-08-22 JP JP2010521478A patent/JP5404625B2/en active Active

Also Published As

Publication number	Publication date
RU2010110658A (en)	2011-09-27
CN101854919B (en)	2012-02-15
CN101854919A (en)	2010-10-06
JP2010536837A (en)	2010-12-02
RU2488384C2 (en)	2013-07-27
BRPI0816144A2 (en)	2015-02-18
JP5404625B2 (en)	2014-02-05
ES2535401T3 (en)	2015-05-11

Publication	Publication Date	Title
GB0700534D0 (en)	2007-02-21	Composition
GB0717182D0 (en)	2007-10-17	Composition
PL2118255T5 (en)	2024-07-29	DETERGENTt COMPOSITION
ZA200907382B (en)	2010-12-29	Composition
GB0722550D0 (en)	2007-12-27	Composition
ZA200908273B (en)	2011-02-23	Composition
ZA200907615B (en)	2010-07-28	Biofertiliser composition
GB0710888D0 (en)	2007-07-18	Composition
GB0716591D0 (en)	2007-10-03	Composition
ZA200908272B (en)	2011-02-23	Composition
GB0705885D0 (en)	2007-05-02	Composition
GB0706343D0 (en)	2007-05-09	Composition
GB0702446D0 (en)	2007-03-21	Composition
GB0703719D0 (en)	2007-04-04	Composition
GB0707972D0 (en)	2007-05-30	Composition
GB0706739D0 (en)	2007-05-16	Composition
GB0704651D0 (en)	2007-04-18	Composition
ZA200906258B (en)	2010-10-27	Composition
GB0723825D0 (en)	2008-01-23	Composition
GB0721430D0 (en)	2007-12-12	Composition
GB0713976D0 (en)	2007-08-29	Composition
GB0709282D0 (en)	2007-06-20	Composition
GB0715705D0 (en)	2007-09-19	Composition
GB0719892D0 (en)	2007-11-21	Composition
GB0719893D0 (en)	2007-11-21	Composition

Legal Events

Date	Code	Title	Description
2009-04-15	AT	Applications terminated before publication under section 16(1)